


Searching News Database: cSSTI
HSMN NewsFeed - 28 Jul 2008
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
HSMN NewsFeed - 6 Sep 2007
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
Additional items found! 3
Members Archive contains
3 additional stories matching:
cSSTI
(Password required)
cSSTI
(Password required)
